Literature DB >> 24322205

Modulation of behavioral networks by selective interneuronal inactivation.

M J Schmidt1, S Horvath2, P Ebert3, J L Norris4, E H Seeley4, J Brown3, L Gellert5, M Everheart3, K A Garbett3, T W Grice3, R M Caprioli4, K Mirnics6.   

Abstract

Gamma-aminobutyric acid (GABA)-ergic disturbances are hallmark features of schizophrenia and other neuropsychiatric disorders and encompass multiple interneuronal cell types. Using bacterial artificial chromosome-driven, miRNA silencing technology we generated transgenic mouse lines that suppress glutamic acid decarboxylase 1 (GAD1) in either cholecystokinin (CCK)- or neuropeptide Y (NPY)-expressing interneurons. In situ lipidomic and proteomic analyses on brain tissue sections revealed distinct, brain region-specific profiles in each transgenic line. Behavioral analyses revealed that suppression of GAD1 in CCK+ interneurons resulted in locomotor and olfactory sensory changes, whereas suppression in NPY+ interneurons affected anxiety-related behaviors and social interaction. Both transgenic mouse lines had altered sensitivity to amphetamine albeit in opposite directions. Together, these data argue that reduced GAD1 expression leads to altered molecular and behavioral profiles in a cell type-dependent manner, and that these subpopulations of interneurons are strong and opposing modulators of dopamine system function. Furthermore, our findings also support the hypothesis that neuronal networks are differentially controlled by diverse inhibitory subnetworks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24322205      PMCID: PMC4179403          DOI: 10.1038/mp.2013.167

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  48 in total

1.  GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex.

Authors:  Bidisha Chattopadhyaya; Graziella Di Cristo; Cai Zhi Wu; Graham Knott; Sandra Kuhlman; Yu Fu; Richard D Palmiter; Z Josh Huang
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

Review 2.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems.

Authors:  Dale S Cornett; Michelle L Reyzer; Pierre Chaurand; Richard M Caprioli
Journal:  Nat Methods       Date:  2007-10       Impact factor: 28.547

Review 3.  The ascent of mouse: advances in modelling human depression and anxiety.

Authors:  John F Cryan; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2005-09       Impact factor: 84.694

4.  Distribution of cholecystokinin immunoreactivity in the BALB/c mouse forebrain: an immunocytochemical study.

Authors:  H Meziane; C Devigne; G Tramu; B Soumireu-Mourat
Journal:  J Chem Neuroanat       Date:  1997-03       Impact factor: 3.052

Review 5.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

Review 6.  Critical appraisal of DNA microarrays in psychiatric genomics.

Authors:  Károly Mirnics; Pat Levitt; David A Lewis
Journal:  Biol Psychiatry       Date:  2006-04-17       Impact factor: 13.382

7.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

8.  Genetic background differences and nonassociative effects in mouse trace fear conditioning.

Authors:  Dani R Smith; Michela Gallagher; Mark E Stanton
Journal:  Learn Mem       Date:  2007-09-05       Impact factor: 2.460

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study.

Authors:  R Gerlai
Journal:  Behav Brain Res       Date:  1998-09       Impact factor: 3.332

View more
  22 in total

Review 1.  Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia.

Authors:  Amanda C Mitchell; Yan Jiang; Cyril Peter; Schahram Akbarian
Journal:  Schizophr Res       Date:  2014-10-31       Impact factor: 4.939

Review 2.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

Review 3.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

4.  Cortical Gene Expression After a Conditional Knockout of 67 kDa Glutamic Acid Decarboxylase in Parvalbumin Neurons.

Authors:  Danko Georgiev; Toru Yoshihara; Rika Kawabata; Takurou Matsubara; Makoto Tsubomoto; Yoshio Minabe; David A Lewis; Takanori Hashimoto
Journal:  Schizophr Bull       Date:  2016-03-15       Impact factor: 9.306

Review 5.  Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; Raymond Y Cho; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-03-17       Impact factor: 13.382

Review 6.  Human dermal fibroblasts in psychiatry research.

Authors:  S Kálmán; K A Garbett; Z Janka; K Mirnics
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

7.  Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.

Authors:  Inbar Zohar; Liat Dosoretz-Abittan; Shai Shoham; Marta Weinstock
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

Review 8.  Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders.

Authors:  Sanne M Casello; Rodolfo J Flores; Hector E Yarur; Huikun Wang; Monique Awanyai; Miguel A Arenivar; Rosario B Jaime-Lara; Hector Bravo-Rivera; Hugo A Tejeda
Journal:  Front Neural Circuits       Date:  2022-06-21       Impact factor: 3.342

Review 9.  Alterations in cortical interneurons and cognitive function in schizophrenia.

Authors:  Samuel J Dienel; David A Lewis
Journal:  Neurobiol Dis       Date:  2018-06-22       Impact factor: 5.996

10.  Interaction of maternal immune activation and genetic interneuronal inhibition.

Authors:  Allison Anderson; Thiago C Genaro-Mattos; Luke B Allen; Katalin Koczok; Zeljka Korade; Karoly Mirnics
Journal:  Brain Res       Date:  2021-02-15       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.